Skip to main content

Vestibular Neurectomy Effective for Severe Meniere Disease

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 6, 2024.

via HealthDay

TUESDAY, Aug. 6, 2024 -- Vestibular neurectomy is an effective vertigo treatment in patients with severe Meniere disease, according to a study published online June 7 in the Journal of Clinical Medicine.

Agnieszka JasiƄska-Nowacka, M.D., Ph.D., from the Medical University of Warsaw in Poland, and colleagues evaluated functional outcomes and balance compensation in patients with severe Meniere disease after vestibular neurectomy. The analysis included data from 20 patients with unilateral Meniere disease before and two years after vestibular neurectomy.

The researchers found that all patients reported a complete resolution of vertigo attacks after the vestibular neurectomy, while 95 percent of patients reported functional-level improvement according to a scale proposed by the American Academy of Otolaryngology-Head and Neck Surgery. All patients showed clinical improvement in the Dizziness Handicap Inventory, with the average result decreasing from 81.7 to 16.4. There were no statistically significant differences between the sensory organization test results before and after vestibular neurectomy. There were significant correlations between a patient’s age and postoperative results of the Dizziness Handicap Inventory and posturography.

"Vestibular neurectomy is an effective vertigo treatment in patients with severe Meniere disease with no clinical improvement despite conservative treatment," the authors write. "It results in subjective physical, functional, and emotional improvement, enabling patients to return to daily activities and work."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer

THURSDAY, June 5, 2025 -- For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel...

Endolymphatic Sac Decompression Effective for Vertigo, Migraine

WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...

One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years

TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.